Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata

Recruiting

Phase 2

Alopecia AreataEvaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata

Sponsor:

University of Minnesota

Code:

NCT06747611

Conditions

Alopecia Areata

Alopecia Totalis

Alopecia Universalis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Vancomycin, Neomycin and MTT capsules

Placebo capsules

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-30. This information was provided to ClinicalTrials.gov by University of Minnesota on 2025-09-08.